# A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age

> **NCT07730450** · PHASE4 · RECRUITING · sponsor: **BioNTech SE** · enrollment: 200 (estimated)

## Conditions studied

- COVID-19 Vaccines

## Interventions

- **BIOLOGICAL:** BNT162b2 Vaccine
- **BIOLOGICAL:** Tdap Vaccine

## Key facts

- **NCT ID:** NCT07730450
- **Lead sponsor:** BioNTech SE
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-23
- **Primary completion:** 2027-08-20
- **Final completion:** 2027-08-20
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07730450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07730450, "A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07730450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*